Lobeline hydrochloride|CAS 134-63-4|DC Chemicals

Cas No.:	134-63-4
Chemical Name:	Lobeline hydrochloride
Synonyms:	2-(6-(2-Hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl)-1-phenylethanone hydrochloride;2-(6-(2-hydroxy-2-phenethyl)-1-methyl-2-piperidyl)acetophenone hydrochloride;Lobeline HCL;(-)-Lobeline hydrochloride;alpha-Lobeline hydrochloride;L-Lobeline hydrochloride;LOBELINE HCl, a-(P) PrintBack;LOBELINE HCl, a-(RG);Lobeline hydrochloride;α-Lobeline Hydrochcloride;α-Lobeline hydrochloride;2-[(2R,6S)-6-[(2S)-2-Hydroxy-2-phenyl-ethyl]-1-methyl-2-piperidyl]-1-phenyl-ethanone hydrochloride;(-)-id;a-Lobeline;A-LOBELINE HCL;LOBELINE HCL, A-;(-)-LOBELINE HCL;Einecs 205-150-2;ALPHA-LOBELIN HCL;Lobeline HCl salt;Lobelinhydrochloride;Lobelin Hydrochlorde;B6586;2-[(2S,6S)-6-[(2S)-2-Hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanone;hydrochloride;Lobeline alpha (-) hydrochoride;Prestwick_300;NCGC00094847-01;-Lobeline (hydrochloride);L-Lobeline (hydrochloride);NCGC00094847-02;CHEMBL1321024;SCHEMBL467022;HSDB 3555;BCP31656;Pharmakon1600-01500758;LOBELINE HYDROCHLORIDE;Ethanone, 2-(6-(2-hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl)-1-phenyl-, hydrochloride;2-(6-(beta-Hydroxyphenethyl)-1-methyl-2-piperidyl)acetophenone hydrochloride;SR-01000674047-2;2-((2R,6S)-6-((S)-2-Hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl)-1-phenylethan-1-one hydrochloride;2-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]-1-phenylethanone;hydrochloride;2-(6-(2-Hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl)-1-phenylethan-1-one hydrochloride;DTXSID201036359;LS-14953;alpha-Lobeline hydrochloride;Lobeline HCl;(c) paragraph sign-Lobeline hydrochloride; L-Lobeline hydrochloride;Acetophenone, 2-(6-(beta-hydroxyphenethyl)-1-methyl-2-piperidyl)-, hydrochloride;134-63-4;63990-84-1;Zoolobelin;SR-01000674047;AKOS016002128;alpha-Lobeline (hydrochloride);L-Lobeline (hydrochloride);FT-0631780;HMS1921G12;C22H28ClNO2;SPECTRUM1500758;NSC757421;SR-01000674047-3;CCG-38841
SMILES:	Cl[H].O([H])[C@]([H])(C1C([H])=C([H])C([H])=C([H])C=1[H])C([H])([H])[C@@]1([H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])C(C2C([H])=C([H])C([H])=C([H])C=2[H])=O)N1C([H])([H])[H]
Formula:	C₂₂H₂₈ClNO₂
M.Wt:	373.9162
Purity:	>98%
Sotrage:	0°C (short term), -20°C (long term), desiccated

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.